Industrial products company CSW (NYSE: CSW) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 33% year on year to $350.7 million. Its non-GAAP profit of $3.84 per share was 10.9% above analysts’ consensus estimates.

Is now the time to buy CSW? Find out by accessing our full research report, it’s free.

Total revenue increased 33% to a record of $351 million, driven by acquisitions as well as organic growthContractor Solutions Segment delivered organic revenue growth of 6%Earnings per diluted share ("EPS") of $3.04 increased 25% compared to $2.43, driven primarily by increased revenueAdjusted EPS, which excludes the amortization of acquisition-related intangible assets and nonrecurring expenses, was a record $3.84 and increased 35% compared to $2.85Net income attributable to CSW of $50 million increased 22% compared to $41 millionAdjusted EBITDA increased 48% to a record $102 million, capitalizing on increased revenueCash flows from operations were a record $76 million, increasing 25%Net debt of $815 million at the end of the quarter, resulting in a net leverage ratio (net Debt to EBITDA), in accordance with our credit facility, of 2.37x, within our stated target range of 1-3x, and decreasing from our fiscal year-end Comments from the Chairman, President, and Chief Executive Officer

Company Overview

With over two centuries of combined operations manufacturing and supplying, CSW (NYSE: CSW) offers special chemicals, coatings, sealants, and lubricants for various industries.

Revenue Growth

A company’s long-term sales performance is one signal of its overall quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Thankfully, CSW’s 19% annualized revenue growth over the last five years was incredible. Its growth surpassed the average industrials company and shows its offerings resonate with customers, a great starting point for our analysis.

We at StockStory place the most emphasis on long-term growth, but within industrials, a half-decade historical view may miss cycles, industry trends, or a company capitalizing on catalysts such as a new contract win or a successful product line. CSW’s annualized revenue growth of 19.7% over the last two years aligns with its five-year trend, suggesting its demand was predictably strong.

This quarter, CSW reported wonderful year-on-year revenue growth of 33%, and its $350.7 million of revenue exceeded Wall Street’s estimates by 2.4%.

Looking ahead, sell-side analysts expect revenue to grow 9.5% over the next 12 months, a deceleration versus the last two years. Despite the slowdown, this projection is admirable and suggests the market is baking in success for its products and services.

ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.

AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.

Operating Margin

Operating margin is one of the best measures of profitability because it tells us how much money a company takes home after procuring and manufacturing its products, marketing and selling those products, and most importantly, keeping them relevant through research and development.

CSW’s operating margin has generally stayed the same over the last 12 months, averaging 18.4% over the last five years. This profitability was elite for an industrials business thanks to its efficient cost structure and economies of scale. This is seen in its fast historical revenue growth and healthy gross margin, which is why we look at all three data points together.

Analyzing the trend in its profitability, CSW’s operating margin might have fluctuated slightly but has generally stayed the same over the last five years. This raises questions about the company’s expense base because its revenue growth should have given it leverage on its fixed costs, resulting in better economies of scale and profitability.

This quarter, CSW generated an operating margin profit margin of 22.8%, up 2 percentage points year on year. The increase was encouraging, and because its operating margin rose more than its gross margin, we can infer it was more efficient with expenses such as marketing, R&D, and administrative overhead.

Earnings Per Share

We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company’s growth is profitable.

CSW’s EPS grew at 29.4% compounded annual growth rate over the last five years, higher than its 19% annualized revenue growth. This tells us the company became more profitable on a per-share basis as it expanded.

Like with revenue, we analyze EPS over a shorter period to see if we are missing a change in the business.

For CSW, its two-year annual EPS growth of 27.1% was lower than its five-year trend. We still think its growth was good and hope it can accelerate in the future.

In Q2, CSW reported adjusted EPS of $3.84, up from $2.43 in the same quarter last year. This print easily cleared analysts’ estimates, and shareholders should be content with the results. Over the next 12 months, Wall Street expects CSW’s full-year EPS to grow 8.9% from $11.36 to $12.37.

Key Takeaways from CSW’s Q2 Results

We were impressed by how significantly CSW blew past analysts’ EBITDA expectations this quarter. We were also glad its revenue outperformed Wall Street’s estimates. Zooming out, we think this was a solid print. The stock traded up 3.2% to $281.41 immediately following the results.

Indeed, CSW had a rock-solid quarterly earnings result, but is this stock a good investment here? We think that the latest quarter is only one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here (it’s free).